Strategies to Control Specialty Drug Costs Without Denying Coverage
Specialty medications — high-cost drugs that treat complex, chronic, or rare conditions — continue to be the primary drivers of...
J. Bradley Nelson, PharmD, CSMC's Posts
Understanding the Growing Link Between COVID-19 and Diabetes
“Can COVID-19 Cause Diabetes?” “COVID-19 and the potential link to diabetes” “New type 2 diabetes diagnoses in youth climbed 77%...
What Does a Type 2 Diabetes Diagnosis Truly Cost?
The primary focus of the employer benefits advisory industry tends to gravitate to the most expensive or new-to-market medication. Why?...
The Role of Mail Order Prescription Services
It can be argued that few developments in the history of the pharmacy benefits industry have had as much impact...
Cancer Drug Pipeline 2021: How to Improve Affordability for Plans & Members
In a year of COVID-19 and the race to an effective vaccine, news about several breakthrough treatments for cancer got...
Why the 2021 Drug Pipeline Will Make You Rethink Your Pharmacy Benefits Strategies
Top Three Things You'll Learn Potential blockbuster specialty drugs in the pipeline for 2021-2022 How the new drugs coming to...
Analyzing the Value of Retail-30 vs Retail-90 Benefit Design Strategies
Dispensing a 90-day supply of medications has become a common benefit design in prescription drug programs today. Proponents tout lower costs...
How the Pharmacy Benefits Industry Has Changed Over the Last Two Decades
What You'll Learn Changes in the drug product mix and the impact on pharmacy benefits plan sponsors How specialty...
DAW Penalties: Promoting Lower-Cost Generics Over Brand-Name Drugs
A generic-first strategy has proven to be a successful strategy used by self-funded employers to manage high prescription drug costs....
